Company: SIMA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026255
Chunk: 61

Company: SIM Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 61
---
. economy, accounting for roughly 18% of gross domestic product, or $4.7 trillion estimated
in 2023. By 2030, expenditures are expected to reach $6.8 trillion. We expect a rapidly aging population and continued advances in clinical
care and enabling technology to fuel a continuation of this growth well into the future, as the healthcare industry is expected to maintain
an average growth rate of approximately 5.5% per year from 2023 to 2030.

We believe the growth in healthcare
expenditure has put pressure on all industry participants (including consumers, employers, insurers, providers, and government agencies)
to manage costs. Therefore, organizations must derive greater value from each dollar spent in healthcare. This required evolution of industry
participants, coupled with the fragmented nature of the healthcare industry, creates a landscape that we believe is rife with potential
investment opportunities.

Competitive Differentiation

Our mission is to create attractive
risk-adjusted returns for our shareholders. Our Management Team seeks to identify, acquire and operate a business that will benefit from
their involvement by utilizing the following differentiating factors to our advantage:

●Industry Expertise: Healthcare
is a broad, diverse and truly local industry comprised of numerous sub-sectors that each require unique institutional knowledge to be
properly analyzed. Our Management Team has the ability to draw on a vast experience set to drive value creation for shareholders.

●Sourcing: Our Management Team has
an extensive network of relationships with private equity and venture capital funds, industry executives, private owners, advisors and
other intermediaries that will provide proprietary deal-sourcing opportunities. Additionally, our directors, officers and advisors are
in constant communication with a wide variety of companies in the healthcare space.

●Execution: The members of our Management
Team have executed a number of healthcare-related investments and SPAC Business Combinations, including Spectral AI (NASDAQ: MDAI), where
Mr. Spangenberg is the company’s founding and largest external shareholder, and Immunome Inc. (NASDAQ: IMNM), where Broadband Capital
was a significant investor during Mr. Kutcher’s tenure with the firm, and where he served as interim Chief Financial Officer. We
believe this experience should allow for compelling structuring solutions that create true alignment between management and shareholders,
as well as efficient negotiations and pricing.

●Capital Markets Expertise:  Our
Management Team and its affiliates are well-versed in capital markets activities, and have made (or advised on) significant